Clinical Trials Logo

Clinical Trial Summary

Purpose:

The main objective of this study is to determine endomicroscopic features of Crohn´s disease.

Background:

Crohn´s disease is an inflammatory disease of the intestines that may affect any part of the gastrointestinal tract from anus to mouth, causing a wide variety of symptoms. Diagnosis is based on several histologic features including transmural pattern of inflammation, crypt abscesses and granulomas. Confocal laser endomicroscopy (CLE) is rapidly emerging as a valuable tool for gastrointestinal endoscopic imaging, enabling the endoscopist to obtain an "optical biopsy" of the gastrointestinal mucosa during the endoscopic procedure.

Scope:

In patients with Crohn´s disease.


Clinical Trial Description

Methods:

Patients underwent colonoscopy for the evaluation of Crohn´s disease. During the endoscopic procedure CLE will be performed.

Procedure:

The patient underwent colonoscopy. During the procedure the patient will receive intravenous fluorescein or topical mucosal staining with acriflavin or cresyl violet, followed by in-vivo CLE of the tissue. Confocal images are digitally saved and analyzed afterwards. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01102855
Study type Observational
Source University of Erlangen-Nürnberg Medical School
Contact
Status Completed
Phase N/A
Start date October 2009
Completion date August 2011

See also
  Status Clinical Trial Phase
Completed NCT01860651 - Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease N/A
Completed NCT01279577 - Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease Phase 2
Completed NCT01086553 - 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease Phase 3
Completed NCT02763293 - Osteopathy Non-manipulative in Patients With Crohn's Disease. N/A
Completed NCT01289366 - Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) N/A
Recruiting NCT06006039 - The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
Recruiting NCT04022083 - Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
Completed NCT03890445 - Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
Completed NCT01564823 - Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease Phase 3
Completed NCT01768858 - Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Completed NCT01417702 - Endoscopy for Assessment of Mucosal Healing in IBD
Completed NCT01417715 - Endomicroscopy for Assessment of Mucosal Healing
Terminated NCT00862121 - A Study With Pentasa in Patients With Active Crohn's Disease Phase 3